Heart Failure POC and LOC Devices Market - 2024-2033

July 2025 | 207 pages | ID: H041572E1CD2EN
DataM Intelligence

Abstracts

The Heart Failure POC and LOC Devices Market was valued at US$ 127.79 Million in 2024 and is anticipated to reach US$ 451.93 Million by 2033, at a CAGR of 0.152 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Heart Failure POC and LOC Devices Market.

This report delivers a comprehensive overview of the Heart Failure POC and LOC Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Heart Failure POC and LOC Devices Market. The Heart Failure POC and LOC Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

Heart Failure POC and LOC Devices Market Scope:

Key Players

• Abbott
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers
• QuidelOrtho Corporation
• Jant Pharmacal Corporation
• Trinity Biotech
• bioMerieux
• Beckman Coulter, Inc. ( LIST NOT EXHAUSTIVE )

Major Highlights

This report delivers a comprehensive overview of the Heart Failure POC and LOC Devices Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Heart Failure POC and LOC Devices Market. The Heart Failure POC and LOC Devices Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS

3.1. Key Trends and Future Projections
3.2. Snippet by Test Type
3.3. Snippet by Technology
3.4. Snippet by Product Type
3.5. Snippet by End-User
3.6. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Rising Technological Advancements
    4.1.1.2. Rising Prevalence of Heart Failure
  4.1.2. Restraints
    4.1.2.1. High Cost of Advanced Devices and Limited Reimbursement
    4.1.2.2. Data Security and Interoperability Concerns
  4.1.3. Opportunity
    4.1.3.1. Integration of AI and Predictive Analytics in POC Devices
    4.1.3.2. Miniaturization and Battery-Free Operation
  4.1.4. Impact Analysis

5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

5.1. Market Leaders and Pioneers
  5.1.1. Emerging Pioneers and Prominent Players
  5.1.2. Established Leaders with the Largest Marketing Brand
  5.1.3. Market Leaders with Established Products
5.2. Latest Developments and Breakthroughs
5.3. Regulatory and Reimbursement Landscape
  5.3.1. North America
  5.3.2. Europe
  5.3.3. Asia Pacific
  5.3.4. South America
  5.3.5. Middle East & Africa
5.4. Porter’s Five Forces Analysis
5.5. Supply Chain Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. Unmet Needs and Gaps
5.9. Recommended Strategies for Market Entry and Expansion
5.10. Pricing Analysis and Price Dynamics

6. HEART FAILURE POC AND LOC DEVICES MARKET, BY TEST TYPE

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  6.1.2. Market Attractiveness Index, By Test Type
6.2. Proteomic Testing*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Metabolomic Testing
6.4. Genomic Testing

7. HEART FAILURE POC AND LOC DEVICES MARKET, BY TECHNOLOGY

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  7.1.2. Market Attractiveness Index, By Technology
7.2. Microfluidics*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Array-Based Systems
7.4. Others

8. HEART FAILURE POC AND LOC DEVICES MARKET, BY PRODUCT TYPE

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  8.1.2. Market Attractiveness Index, By Product Type
8.2. Wearable Devices*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Implantable Devices
8.4. Handheld Devices

9. HEART FAILURE POC AND LOC DEVICES MARKET, BY END-USER

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Homecare Settings
9.5. Assisted Living Healthcare Facilities
9.6. Laboratories
9.7. Others

10. HEART FAILURE POC AND LOC DEVICES MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    10.1.1.1. Market Attractiveness Index, By Region
10.2. North America
  10.2.1. Introduction
  10.2.2. Key Region-Specific Dynamics
  10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.2.7.1. U.S.
    10.2.7.2. Canada
    10.2.7.3. Mexico
10.3. Europe
  10.3.1. Introduction
  10.3.2. Key Region-Specific Dynamics
  10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.3.7.1. Germany
    10.3.7.2. UK
    10.3.7.3. France
    10.3.7.4. Spain
    10.3.7.5. Italy
    10.3.7.6. Rest of Europe
10.4. Asia-Pacific
  10.4.1. Introduction
  10.4.2. Key Region-Specific Dynamics
  10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.4.7.1. China
    10.4.7.2. India
    10.4.7.3. Japan
    10.4.7.4. South Korea
    10.4.7.5. Rest of Asia-Pacific
10.5. South America
  10.5.1. Introduction
  10.5.2. Key Region-Specific Dynamics
  10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.5.7.1. Brazil
    10.5.7.2. Argentina
    10.5.7.3. Rest of South America
10.6. Middle East and Africa
  10.6.1. Introduction
  10.6.2. Key Region-Specific Dynamics
  10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

12. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS

12.1. Market Share Analysis and Positioning Matrix
12.2. Strategic Partnerships, Mergers & Acquisitions
12.3. Key Developments in Product Portfolios and Innovations
12.4. Company Benchmarking

13. COMPANY PROFILES

13.1. Abbott*
  13.1.1. Company Overview
  13.1.2. Product Portfolio
    13.1.2.1. Product Description
    13.1.2.2. Product Key Performance Indicators (KPIs)
  13.1.3. Financial Overview
    13.1.3.1. Company Revenue
    13.1.3.2. Geographical Revenue Shares
    13.1.3.3. Revenue Forecasts
  13.1.4. Key Developments
    13.1.4.1. Mergers & Acquisitions
    13.1.4.2. Key Product Development Activities
    13.1.4.3. Regulatory Approvals, etc.
    13.1.4.4. SWOT Analysis
13.2. F. Hoffmann-La Roche Ltd
13.3. Siemens Healthineers
13.4. QuidelOrtho Corporation
13.5. Jant Pharmacal Corporation
13.6. Trinity Biotech
13.7. bioM?rieux
13.8. Beckman Coulter, Inc. ( LIST NOT EXHAUSTIVE )

14. ASSUMPTIONS AND RESEARCH METHODOLOGY

14.1. Data Collection Methods
14.2. Data Triangulation
14.3. Forecasting Techniques
14.4. Data Verification and Validation

15. APPENDIX

15.1. About Us and Services
15.2. Contact Us